Cargando…
Enhanced Biosynthesis of 2-Deoxy-scyllo-inosose in Metabolically Engineered Bacillus subtilis Recombinants
2-Deoxy-scyllo-inosose (DOI) has been a valuable starting natural product for the manufacture of pharmaceuticals or chemical engineering resources such as pyranose catechol. DOI synthase, which uses glucose-6-phosphate (Glc6P) as a substrate for DOI biosynthesis, is indispensably involved in the ini...
Autores principales: | Lim, Joo Hyun, Hwang, Hyun Ha, Lee, Na Joon, Lee, Jae Woo, Seo, Eun Gyo, Son, Hye Bin, Kim, Hye Ji, Yoon, Yeo Joon, Park, Je Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170601/ https://www.ncbi.nlm.nih.gov/pubmed/30319595 http://dx.doi.org/10.3389/fmicb.2018.02333 |
Ejemplares similares
-
Metabolically engineered recombinant Saccharomyces cerevisiae for the production of 2-Deoxy-scyllo-inosose (2-DOI)
por: Al-Fahad, Ahmed J., et al.
Publicado: (2020) -
A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production
por: Tanaka, Kosei, et al.
Publicado: (2017) -
An improved Bacillus subtilis cell factory for producing scyllo-inositol, a promising therapeutic agent for Alzheimer’s disease
por: Tanaka, Kosei, et al.
Publicado: (2013) -
Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD(+)-dependent scyllo-inositol dehydrogenase
por: Kang, Dong-Min, et al.
Publicado: (2017) -
A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease
por: Yamaoka, Masaru, et al.
Publicado: (2011)